Abstract
The purpose of this study was to clarify the underlying mechanism of vertiginous attacks in Ménière’s disease (MD) while obtaining insight into water homeostasis in the inner ear using a new animal model. We conducted both histopathological and functional assessment of the vestibular system in the guinea-pig. In the first experiment, all animals were maintained 1 or 4 weeks after electrocauterization of the endolymphatic sac of the left ear and were given either saline or desmopressin (vasopressin type 2 receptor agonist). The temporal bones from both ears were harvested and the extent of endolymphatic hydrops was quantitatively assessed. In the second experiment, either 1 or 4 weeks after surgery, animals were assessed for balance disorders and nystagmus after the administration of saline or desmopressin. In the first experiment, the proportion of endolymphatic space in the cochlea and the saccule was significantly greater in ears that survived for 4 weeks after surgery and were given desmopressin compared with other groups. In the second experiment, all animals that underwent surgery and were given desmopressin showed spontaneous nystagmus and balance disorder, whereas all animals that had surgery but without desmopressin administration were asymptomatic. Our animal model induced severe endolymphatic hydrops in the cochlea and the saccule, and showed episodes of balance disorder along with spontaneous nystagmus. These findings suggest that administration of desmopressin can exacerbate endolymphatic hydrops because of acute V2 (vasopressin type 2 receptor)-mediated effects, and, when combined with endolymphathic sac dysfunction, can cause temporary vestibular abnormalities that are similar to the vertiginous attacks in patients with MD.
Similar content being viewed by others
Main
Ménière’s disease (MD) is a well-known inner ear disorder characterized by symptoms including recurring attacks of vertigo typically lasting for hours, fluctuating sensorineural hearing loss, and tinnitus. Since the milestone findings on the temporal bones of MD patients,1, 2 endolymphatic hydrops (EH) has been considered as the histopathological origin of MD, as characteristic morphological changes were reported to be produced by surgical obstruction of the endolymphatic sac (ES) in guinea-pig.3 This observation indicates that malabsorption of endolymph in the ES is one of the possible mechanisms underlying the development of EH. This experimentally induced EH has been frequently used as an animal model to investigate the pathogenesis of inner ear disorders associated with EH. In terms of vestibular function, while canal dysfunction and/or spontaneous nystagmus have been occasionally observed in this animal model,4, 5 episodes of vertiginous attack or balance disorder have only rarely been observed.6 In other words, this model is insufficient for fully representing the common symptoms of MD.
Water homeostasis of the inner ear is essential for maintaining the functions of hearing and balance. EH is considered to be the result of disruption of inner ear water homeostasis, which involves excessive production of endolymph and/or reduced absorption of endolymph. Until recently, however, the detailed mechanisms underlying the overaccumulation of endolymph were unclear. Since the discovery of aquaporin (AQP) water channels,7 it has been proposed that precise regulation of water reabsorption largely depends on the regulation of AQP2 channels and that water permeability can change rapidly in response to vasopressin(VP).8 Recently, it has come to light that this mechanism has a crucial role not only in the kidney but also in the inner ear. In addition, the following evidence has accumulated to suggest that VP is closely associated with the formation of EH: (1) plasma levels of arginine VP are higher in patients with MD and may depend on the phase that the patient is in,9, 10, 11 (2) acute and chronic application of arginine VP produces EH in guinea-pigs and rats,12, 13, 14 (3) V2 receptor mRNA is expressed in rat and human inner ear,15, 16, 17, 18 and (4) expression of V2 receptor mRNA in the rat inner ear is downregulated by VP application.19 Such accumulated evidence has led to the assumption that production of endolymph is controlled by VP–AQP2 system.
In a previous study using an animal model of MD, Dunnebier et al20 reported chronic ES dysfunction induced by destruction of the ES, and acute stress-induced endolymph production by aldosterone administration revealed severe degrees of hydrops in the cochlea.20 In this investigation, we successfully developed a new clinically relevant animal model for MD, in which desmopressin (a VP type 2 receptor agonist) was administered after electrocauterization of the ES.
We evaluated both morphological and behavioral alterations of the vestibular system in this animal model to elucidate the role of VP in the pathogenesis of MD.
MATERIALS AND METHODS
This study was composed of two experiments. Experiment 1 was designed to investigate the influence of desmopressin on the development of EH morphologically. Experiment 2 was designed to investigate the role of desmopressin on changes in vestibular function. The animals used in Experiment 1 were albino outbred English short-haired guinea-pig (Hartley). In Experiment 2, pigmented English short-haired guinea-pig were used. Pigmented animals were selected for Experiment 2 to facilitate eye movement recording using an infrared-sensitive CCD camera.
These experiments were approved by Tokyo University Animal Care and Use Committee, and were conducted in accordance with The Animal Welfare Act and the guiding principles for animal care produced by the Ministry of Education, Culture, Sports, and Technology, Japan.
Experiment 1
Animals
A total of 24 guinea-pigs with a positive Preyer’s reflex and weighing approximately 300 g were used in this experiment. All animals underwent electrocauterization of the ES of the left ear as reported previously.21, 22 The right ear was not treated surgically. The surgical procedures are described below (in the Surgical procedure for electrocauterization of the ES section). Animals were divided into two major groups. Twelve animals were allocated to survive for 1 week after electrocauterization of the ES and the other 12 for 4 weeks. In either group, six animals were given saline and the remaining six were treated with desmopressin systemically 1 h before euthanasia. In animals treated with desmopressin, 100 μg/kg (25 ml/kg) desmopressin acetate hydrate (desmopressin 4; Kyowa Hakko Kirin, Tokyo, Japan) was administered subcutaneously 1 h before euthanasia. In saline-treated animals, 25 ml/kg saline solution was administered subcutaneously 1 h before euthanasia. All animals were killed under deep anesthesia using ketamine and xylazine, and the temporal bones were collected from both sides. As shown in Figure 1a, 48 temporal bones harvested were classified into eight groups (n=6) according to the presence or absence of surgery, the survival duration, and type of treatment: (1) right temporal bones, 1-week survival after left ear electrocauterization, administered saline (1 W Control group (RIGHT)); (2) left temporal bones of the above-mentioned animals (1 W Surgery group (LEFT)); (3) right temporal bones, 1-week survival after left ear electrocauterization, administered desmopressin (1 W Desmopressin group (RIGHT)); (4) left temporal bones of the above-mentioned animals (1 W Combined group (LEFT)); (5) right temporal bones, 4-week survival after left ear electrocauterization, administered saline (4 W Control group (RIGHT)); (6) left temporal bones of the above-mentioned animals (4 W Surgery group (LEFT)); (7) right temporal bones, 4-week survival after left ear electrocauterization, administered desmopressin (4 W Desmopressin group (RIGHT)), and (8) left temporal bones of the above-mentioned animals (4 W Combined group (LEFT)).
Surgical procedure for Electrocauterization of the ES
All experimental animals were anesthetized by an intramuscular injection of ketamine (35 mg/kg) and xylazine (5 mg/kg). The animals received local anesthesia using xylocaine under sterile conditions. Subsequently, they were placed in a prone position with a head holder and underwent dorsal midline scalp incision. The left occipital bone was removed for visual exposure of the ES via an epidural occipital approach. Thereafter, the extraosseous portion of the sac was cauterized electrically with a bipolar electrocoagulator (Surgitron Model FFPF; Ellman International, Hewlett, NY, USA) so as not to injure the sigmoid sinus. The operation was performed using a Carl Zeiss operation microscope.
Quantitative Assessment of the Endolymphatic Space
Under deep anesthesia by an intraperitoneal injection of ketamine (35 mg/kg) and xylazine (5 mg/kg), all animals were perfused from the left ventricle with physiological saline solution, and then fixed with 10% formalin. The temporal bones were removed on both sides and postfixed in 10% formalin solution for 7 days. Subsequently, the specimens were decalcified in ethylenediamine tetraacetic acid for 14 days, and then dehydrated in a graded ethanol series before being embedded in paraffin. The prepared blocks were cut horizontally parallel to the axis of the modiolus into 6-μm sections. The sections were stained with hematoxylin and eosin for observation under a light microscope. We examined the degree of EH in the cochleae, vestibules, and semicircular canals using digital image measurement software, Micro Analyzer Ver. 1.1 (Nippon Poladigital, Tokyo, Japan). To assess quantitatively the endolymphatic space variations across the cochlea turns, we measured the increase in the ratio of the cross-sectional area of the scala media (IR-S) in the basal, second, third, and apical turns, excluding the hook portion at the mid-modiolar sections. For this analysis, we used the following two parameters: (1) the cross-sectional area of the dilated scala media (Figure 2a, gray area), and (2) the cross-sectional area of the original scala media, enclosed by a straight line segment (Figure 2a, black area). This line segment represents the normal position of Reissner’s membrane at the upper margin of the stria vascularis and its normal medial attachment at the spiral limbus. From these parameters, we calculated the increased ratios (%) of the cross-sectional area of the scala media (IR-S) of a total of four turns using the following formula:
Total IR-S (%)=100 × (∑(Ax−Bx)/xBx) (x: basal second, third, apical turn)
For the quantitative assessment of the spread of the endolymphatic space of the saccule, we measured the proportion of the area of the saccule (Figure 2b, gray area) relative to that of the vestibule (Figure 2b, black area) in the horizontal section including the stapes footplate. In the utricle, we also examined the proportion of the area of the utricle (Figure 2c, gray area) to that of the labyrinth (Figure 2c, black area) in the horizontal section including the crista of the lateral semicircular canal. For the semicircular canal, we examined the area of endolymph of the posterior semicircular canal (Figure 2d, gray area) relative to the area of bony posterior semicircular canal (Figure 2d, black area) in the horizontal section including the crista of the posterior semicircular canal.
Statistical Analyses
Differences in the degree of endolymph space by surgical procedure were evaluated for individual subjects by paired t-test. We compare the differences in the mean values among each group with Tukey’s multiple comparison test. StatMate IV (ATMS, Tokyo, Japan) was used to conduct these analyses. The data are presented as mean±s.d., unless otherwise noted. A difference of P<0.05 was considered significant.
Experiment 2
Animals
A total of 24 pigmented guinea-pigs with a positive Preyer’s reflex weighing approximately 300 g were used. Sixteen animals underwent electrocauterization of the ES in the left ear, and the remaining eight animals received no surgical procedure. The 16 animals that underwent surgery were divided into two groups, which were maintained for 1 week or 4 weeks before administration of saline or desmopressin. In either group, four animals were given saline and the remaining four animals were given desmopressin. Saline and desmopressin treatments were performed in the same manner as in Experiment 1. Animals that underwent surgery were assessed for evidence of a balance disorder and the presence of nystagmus for 1 h after they received a subcutaneous injection of 25 ml/kg saline solution, or 100 μg/kg (25 ml/kg) desmopressin acetate hydrate. Similarly in the eight surgery-free animals, vestibular examinations were undertaken for 1 h after administration of saline or desmopressin.
As shown in Figure 1b, experimental animals were classified into six groups (n=4) according to the presence or absence of surgery, the survival duration, and type of treatment: (1) V-Control group: surgery-free animals administered saline; (2) V-Desmopressin group: surgery-free animals administered desmopressin; (3) V-Surgery-1 W group: animals given saline 1 week after electrocauterization of the ES; (4) V-Combined-1 W group: animals given desmopressin 1 week after electrocauterization of the ES; (5) V-Surgery-4 W group: animals given saline 4 weeks after electrocauterization of the ES; and (6) V-Combined-4 W group: animals given desmopressin 4 weeks after electrocauterization of the ES.
Vestibular Examinations
We recorded spontaneous nystagmus with an eye movement recording system in a dark room for 1 h after administration of saline or desmopressin. The maximum slow-phase velocity was measured. The recording procedure has been described previously.5 The dark iris can be detected using an infrared-sensitive CCD camera to produce a binary image; the eye position and velocity are then calculated by a personal computer. We also monitored posture for 1 h after the administration of saline or desmopressin to determine the presence or absence of a balance disorder. Postural disturbances during a vestibular attack were videotaped.
RESULTS
Experiment 1
Figures 3 and 4 show representative pictures of the cochlea and the saccule in the four following groups: 4 W Control group, 4 W Surgery group, 4 W Desmopressin group, and 4 W Combined group. Reissner’s membrane was almost straight in the 4 W Control group and 4 W Desmopressin group (Figures 3a and c), whereas it was moderately extended in the 4 W Surgery group (Figure 3b), and bulged into the scala vestibuli in the 4 W Combined group (Figure 3d). Saccular hydrops was not observed in the 4 W Control group or the 4 W Desmopressin group (Figures 4a and c), whereas the saccular space was moderately extended in the 4 W Surgery group (Figure 4b). In the 4 W Combined group, the saccular space was markedly extended and the saccular membrane was widely adhered to the stapes footplate (Figure 4d). There was no significant hydrops in the utricle or semicircular canal in any group, except that one animal in 4 W Combined group showed a slight expansion of the utricular space.
Figure 5 shows the results of quantitative analyses of the changes in the endolymphatic space in the cochlea, saccule, utricle, and the semicircular canal. In the cochlea, total IR-S (%) in the 1 W or 4 W Combined group showed a significantly greater ratio compared with the 1 W or 4 W Desmopressin group (paired t-test, P<0.05 and P<0.01, respectively; Figure 5a). In the 4 W Surgery group, the IR-S was significantly greater than that of the 4 W Control group (paired t-test, P<0.05; Figure 5a); however, the IR-S was not significantly different between 1 W Control group and 1 W Surgery group (paired t-test, P>0.05; Figure 5a). Total IR-S (%) in the 4 W Combined group was significantly greater when compared with the 1 W Surgery group, 1 W Combined group, and 4 W Surgery group (Tukey’s multiple comparison test, P<0.001; Figure 5a). There were no significant differences among 1 W and 4 W Control groups and 1 W and 4 W Desmopressin groups (Tukey’s multiple comparison test, P>0.05; Figure 5a). Total IR-S (%) was significantly greater in the 4 W Combined group than in the 4 W Surgery group, and also in the 1 W Combined group than in the 1 W Surgery group (t-test, P<0.05; Figure 5a).
We also estimated the progression of cochlea EH in the Surgery and Combined groups. In the Surgery group, EH appeared to gradually develop over a time scale of weeks. The average growth rates of EH development in the Surgery group were estimated from the IR data in the 1 W or 4 W groups using the following formula: (IR-S (%) of the 1 W or 4 W Surgery groups−IR-S (%) of the 1 W or 4 W Control groups)/168 h (1 W) or 672 h (4 W). The average growth rates of EH development were 0.008%/h in the 1 W group and 0.025%/h in the 4 W group. In the Combined group, EH appeared to develop within 1 h of desmopressin administration. The average growth rates of EH development were estimated from the IR data using the following formula: IR-S (%) of the 1 W or 4 W Combined group−IR-S (%) of the 1 W or 4 W Surgical group. The average growth rates of EH development were 27.2−14.7%=12.5%/h and 60.0−36.3%=23.7%/h for the 1 W and 4 W groups, respectively.
The proportion of the saccular space was greater in the 1 W Combined group compared with the 1 W Desmopressin group (paired t-test, P<0.05; Figure 5b) and in the 4 W Combined group compared with the 4 W Desmopressin group (paired t-test, P<0.001; Figure 5b). In the 1 W and 4 W Surgery groups, the proportion of the saccular space was significantly greater compared with the 1 W and 4 W Control groups (paired t-test, P<0.05 in both comparisons; Figure 5b). The proportion of the saccular space in the 4 W Combined group was significantly greater when compared with the 1 W Surgery group, 1 W Combined group, and 4 W Surgery group (Tukey’s multiple comparison test, P<0.001; Figure 5b). There were no significant differences among the 1 W and 4 W Control groups and 1 W and 4 W Desmopressin groups (Tukey’s multiple comparison test, P>0.05; Figure 5b). The proportion of the saccular space was significantly greater in the 4 W Combined group than in the 4 W Surgery group (t-test, P<0.001; Figure 5b), and also in the 1 W Combined group than in the 1 W Surgery group (t-test, P<0.05; Figure 5b).
We also estimated the progression of saccular hydrops in the Surgery and Combined groups. In the Surgery group, saccular hydrops appeared to develop over a time scale of weeks. The average growth rates of development of saccular hydrops was estimated from the proportion of saccular space remaining using the following formula for both the 1 W and 4 W groups: (proportion remaining (%) in the 1 W or 4 W Surgery group−proportion remaining (%) in the 1 W or 4 W Control group)/168 h (1 W) or 672 h (4 W). The average growth rates of development of saccular hydrops were 0.03%/h and 0.02%/h for the 1 W and 4 W groups, respectively. Comparing growth rates of development of saccular hydrops in the Surgery and Combined groups in the same manner yielded average speeds of 25.2−12.7%=12.5%/h for the 1 W group and 51.9−24.6%=27.3%/h for the combined group.
In the utricle, there were no significant differences among the four groups maintained for either 1 week or 4 weeks (Figure 5c). In both the semicircular canal ampulla and the duct, there were also no significant differences among the four groups maintained for either 1 week or 4 weeks (Figures 5d and e).
Experiment 2
All of animals in the V-Combined-1 W and V-Combined-4 W groups showed spontaneous nystagmus (Table 1 and Supplementary Movie 1 in Supplementary Material) and balance disorder (Supplementary Movie 2 in Supplementary Material). After the administration of desmopressin, one animal in the V-Desmopressin group demonstrated spontaneous nystagmus. No animals in the V-Control group, V-Surgery-1 W, and V-Surgery-4 W groups showed any nystagmus. Table 2 shows the maximum slow-phase velocity in the animals in the V-Combined-1 W and V-Combined -4 W groups, which presented spontaneous nystagmus. In cases 2, 6, and 7, the direction of nystagmus changed from the left to the right, indicating a change from irritative nystagmus to paralytic nystagmus. Typically, 10 min after the onset of the irritative nystagmus, the direction of nystagmus changed to the paralytic.
In cases 1, 5, and 8, only paralytic spontaneous nystagmus appeared (Supplementary Movie 1). In cases 3 and 4, only irritative spontaneous nystagmus appeared. The amplitude and direction of the maximum slow-phase velocity varied among the animals.
DISCUSSION
In this investigation, we successfully developed a new clinically relevant animal model for MD, in which desmopressin was administered after electrocauterization of the ES. In this animal model, distinct EH was evident in the cochlea and saccule, whereas there were no obvious changes in the utricle or semicircular canals. Temporal bone studies of patients with MD have revealed that EH is more frequently observed in the pars inferior than in the pars superior of the inner ear. It has been shown that severe EH is observed most frequently in the saccule, followed by the cochlea, utricle, and the semicircular canals.23 Recent studies using magnetic resonance imaging have also confirmed these histopathologic findings.24, 25 In the Surgery group in Experiment 1, ears that underwent electrocauterization of the ES but without administration of desmopressin developed slight to moderate hydrops, indicating that prolonged ES dysfunction induced by electrocauterization may cause malabsorption of endolymph, and thus development of EH. This assumption is in line with following histopathologic findings related to the ES in patients with MD: poor development of the ES,26, 27 fibrotic changes of the ES, and a hypoplastic vestibular aqueduct.28, 29
Experimentally induced EH, first proposed by Kimura and Schuknecht in 1965,3 is well known as an animal model of MD. The EH of their model is thought to involve retention hydrops caused by the obliteration of the endolymphatic duct. This model animal is reported to have spontaneous nystagmus in the dark,5, 6, 30 but not in the light.31 In horizontal vestibular ocular reflex testing, vestibular ocular reflex gain was found to have decreased 1 week after the obliteration of ES.5 These experimental results suggest that EH might contribute to vestibular dysfunction to some extent and that vestibular dysfunction might occur during the development and/or progression of EH. Episodes of temporary imbalance or vertigo, which are typical features of patients with MD, have not however been reported in animals that underwent obliteration of their ES. Therefore, such animals with EH due only to the retention of endolymph are not considered suitable as an animal model of MD.
Considering these issues, we speculated that the lack of temporary vestibular episodes in the classical MD animal model might be related to growth rates of formation of EH, not the degree of EH. That is, the development of EH caused by malabsorption in the ES is too slow to produce a vertiginous attack. Indeed, animals that survived for 4 weeks after electrocauterization of the left ES (4 W Surgery group) developed severe EH in the cochlea and the saccule, but showed no distinct vestibular disorders. Therefore, we modified the classical animal model with the additional administration of desmopressin to accelerate the development of EH.
As expected, animals given desmopressin 1 or 4 weeks after the electrocauterization of the ES showed both spontaneous nystagmus and balance disorders (V-Combined-1 W group and V-Combined-4 W group). Most of the V-Combined group animal showed desmopressin-induced vestibular disorders about 1 h, which agrees with the time course of desmopressin-induced intrastrial space enlargement.32 Morphological changes indicated that animals that survived for 4 weeks after the electrocauterization of the left ES combined with administration of desmopressin (4 W Combined group) had severe EH in the cochlea and the saccule, and that the degree of EH was extremely high compared with animals that survived for only 1 week after electrocauterization of the left ES and the administration of desmopressin (1 W Combined group) even though both groups demonstrated episodes of vestibular dysfunction. The degree of EH and the saccular hydrops in the 1 W and 4 W combined groups was extremely high compared with animals that survived for 1 or 4 weeks after the electrocauterization of the left ES alone (1 W and 4 W Surgery group) (Figure 5a and b). Thus, the disorders of vestibular function could not be rationalized on the basis of the degree of EH. With the dynamic changes of EH in mind, however, another theory could be proposed. In the 1 W and 4 W Surgery groups, EH is thought to develop gradually over 1 and 4 weeks. On the other hand, EH in animals administered desmopressin is thought to develop as rapidly as within 1 h. Analysis of the average growth rates of EH development, estimated from the IR and proportion of saccular space, indicates that animals in the Combined groups had very high growth rates of EH development both in the cochlea and in the saccule, regardless of the survival time between surgery and the measurement. Taking these results into consideration, the desmopressin-induced vestibular disorders in animals in the V-Combined-1 W group are readily understandable.
Generally, EH is well known to exist in cases with a clinical diagnosis of Meniere’s syndrome. Conversely, nearly one-third of the cases of idiopathic hydrops show no association with the classic symptoms of Meniere’s syndrome.33 In addition, previous histopathological examinations have revealed that the contralateral ears of patients with unilateral Meniere’s disease showed asymptomatic saccular hydrops in around 30% of patients.34, 35 Recently, Kato et al36 reported that there was no significant association between the degree of EH and caloric responses, using MRI. Previous studies have suggested that not only static morphological hydrops but also dynamic changes of hydrops may be responsible for the symptoms of MD, and further support the validity of our new animal model for MD.
Endolymph flow measurements show that endolymph does not flow along the cochlea and it is generally agreed that most of the potassium in endolymph is recycled between perilymph and endolymph.37, 38 When the ES is in a normal state, the secretion and absorption of endolymph are well balanced. Previous molecular biological studies revealed that AQP2 mRNA expression in the cochlea as well as in the ES was upregulated by systemic application of VP.39 Morphologically, the endolymphatic space was found to increase in response to systemic application of VP.13 Clinically, Takeda et al9 demonstrated evidence of elevated serum arginine VP levels in patients with MD. Hornibrool et al40 reported that there have not been abnormal plasma levels of arginine VP in patients of MD. The reasons for these controversial results might have been that because platelets present in plasma cause overestimation of plasma arginine VP and partly to avoid degradation of AVP activity resulting from its short half-life,41, 42, 43 it might be one of the most important reasons for the great differences in basal arginine VP concentrations observed in different laboratories. These previous experimental findings indicate that the water homeostasis of the inner ear fluid is partly regulated via the VP–AQP2 system. In this study, desmopressin (V2 agonist) was used to examine the V2 effect of VP, not the vasopressin type 1 (V1) effect, because the V1 receptor, although limited to mRNA, is also expressed in the inner ear.44, 45
On the basis of previous and present investigations, and given that patients with EH alone do not suffer from vertigo, we assume that the pathogenesis of vertiginous attacks is as follows: activation of the VP–AQP2 system by the V2 effect may yield overproduction of endolymph, with an increase in the influx of water from the perilymph into the endolymph, which causes sudden changes in endolymphatic pressure. We speculate that under chronic endolymphatic dysfunction, it may reduce absorption of endolymph and chemical mechanisms can concomitantly cause Meniere’s symptoms. Chemical factors include hydrostatic pressure alterations, it changes membrane permeability, causing inappropriate ion across the membrane barrier so as to incite sensory dendrites and lead to cochlear and vestibular symptoms. In our experiment, we can see a remarkable histopathological change in the cochlea and saccule, not in the utricle and semicircular canals. There remains some discussion about whether an endolymph–perilymph pressure gradient may cause these morphological variations. Previous studies have shown that AQP2 protein and/or mRNA are expressed in the inner ear of rats.19, 39, 46 Furthermore, the V2 receptor and/or its mRNA are found in the cochlea.16, 18 These previous studies suggest that water homeostasis in the inner ear is partly regulated via the VP–AQP2 system. If AQP2 protein and/or mRNA was to be overexpressed in the stria vascularis or vestibular dark cells, the VP–AQP2 system may promote overproduction of endolymph. Therefore, the difference in AQP2 expression in the stria vascularis and the dark cells may cause morphological variations. Further study is needed to determine the mechanism of the VP–AQP2 system in the inner ear using this animal model to understand the relationship between VP and MD.
References
Yamakawa K . Uber die pathologische Veranderung bei einem Meniere-Kranken. J Otorhinolaryngol Soc Jpn 1938;44:2310–2312.
Hallpike CS, Cairns H . Observations on the pathology of Meniere’s syndrome. J Laryngol Otol 1938;53:625–655.
Kimura RS, Schuknecht H . Membranous hydrops in the inner ear of the guinea pig after the obliteration of the endolymphatic sac. Pract Otorhinolaryngol 1965;27:343–354.
Manni JJ, Kuijpers W, Huygen PLM et al. Cochlear and vestibular functions of the rat after obliteration of the endolymphatic sac. Hear Res 1988;36:139–152.
Kakigi A, Taguchi T, Takeda T et al. Time course of vestibular function changes of experimental endolymphatic hydrops in guinea pigs. ORL 2010;71 (Suppl 1):19–25.
Andrews JC, Honrubia V . Vestibular function in experimental endolymphatic hydrops. Laryngoscope 1988;98:479–485.
Agre P, Sasaki S, Chrispeels MJ . Aquaporins: a family of water channel proteins. Am J Physiol Renal Physiol 1993;265:F461.
Nielsen S, Fronkiare J, Marples D et al. Aquaporins in the kidney: from molecules to medicine. Physiol Rev 2002;82:205–244.
Takeda T, Kakigi A, Saito H . Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta Otolaryngol Stockh 1995;519:219–222.
Aoki M, Ando K, Kuze B et al. The association of antidiuretic hormone levels with an attack of Ménière’s disease. Clin Otolaryngol 2005;30:521–525.
Takeda T, Takeda S, Kakigi A et al. Hormonal aspects of Ménière’s disease on the basis of clinical and experimental studies. ORL 2009;71 (Suppl 1):1–9.
Kumagami H, Lowewenheim H, Beitz E et al. The effect of anti-diuretic hormone on the endolymphatic sac of the inner ear. Pflugers Arch 1998;436:970–975.
Takeda T, Takeda S, Kitano H et al. Endolymphatic hydrops induced by chronic administration of vasopressin. Hear Res 2000;140:1–6.
Kitano H, Takeda T, Takeda S et al. Endolymphatic hydrops by administration of vasopressin in the rat. Acta Histochem Cytochem 2001;34:229–233.
Kitano H, Takeda T, Suzuki M et al. Vasopressin and oxytocin receptor mRNAs are expressed in the rat inner ear. NeuroReport 1997;8:2289–2292.
Taguchi D, Takeda T, Kakigi A et al. Expressions of aquaporin-2, vasopressin type 2 receptor, transient receptor potential channel vanilloid (TRPV)1, and TRPV4 in the human endolymphatic sac. Laryngoscope 2007;117:695–698.
Nishimura M, Kakigi A, Takeda T et al. Expression of aquaporins, vasopressin type 2 receptor, and Na+( )K+( )− cotransporters in the rat endolymphatic sac. Acta Otolaryngol 2009;129:812–818.
Nishioka R, Takeda T, Kakigi A et al. Expression of aquaporins and vasopressin type 2 receptor in the stria vascularis of the cochlea. Hear Res 2010;260:11–19.
Kitano H, Suzuki M, Kitanishi T et al. Regulation of inner ear fluid in the rat by vasopressin. NeuroReport 1999;10:1205–1207.
Dunnebier EA, Segenhout JM, Wit HP et al. Two-phase endolymphatic hydrops: a new dynamic guinea pig model. Acta Otolaryngol 1997;117:13–19.
Lee KS, Kimura RS . Ischemia of the endolymphatic sac. Acta Otolaryngol (Stockh) 1992;112:658–666.
Takeda T, Kakigi A, Saito H . Epidural electrocauterization of endolymphatic sac. Equilibrium Res 1993;9 (Suppl):139–143.
Okuno T, Sando I . Localization, frequency and severity of endolymphatic hydrops and the payhology of the labyrinthine membrane in Meniere’s disease. Ann Otol Rhinol Laryngol 1987;96:438–445.
Nakashima T, Naganawa S, Sugiura M et al. Visualization of endolymphatic hydrops in patients with Meniere’s disease. Laryngoscope 2007;117:415–420.
Fiorino F, Pizzini FB, Beltramello A et al. Progression of endolymphatic hydrops in Ménière’s disease as evaluated by magnetic resonance imaging. Otol Neurotol 2011;32:1152–1157.
Shambaugh GE, Clemis JD, Arenberg IK . Endolymphatic duct and sac in Meniere’s disease. 1. Surgical and histopathologic observations. Arch Otolaryngol; 89:816–825.
Takeda T, Sawada S, Kakigi A et al. Computed radiographic measurement of the dimensions of the vestibular aqueduct in Meniere’s disease. Acta Otolaryngol (Stockh) 1997;528 (Suppl):80–84.
Sando I, Ikeda M . The vestibular aqueduct in patients with Meniere’s disease. Acta Otolaryngol (Stockh) 1984;97:558–570.
Egami T, Sando I, Black FO . Hypoplasia of the vestibular aqueduct and endolymphatic sac in endolymphatic hydrops. ORL 1978;86:327–339.
Kusakari J, Kobayashi T, Arakawa E et al. Time-realted changes in cochlear potentials in guinea pigs with experimentally induced endolymphatic hydrops. Acta Oto-Laryngol Suppl 1987;435:27–33.
Kitahara M, Takeda T, Yazawa Y et al. Experimental study on Meniere’s disease. Otolaryngol Head Neck Surg 1982;90:470–481.
Nishimura M, Kakigi A, Takeda T et al. Time course changes of vasopressin-induced enlargement of the rat intrastrial space and the effects of a vasopressin type 2 antagonist. Acta Oto-Laryngol 2009;129:709–715.
Merchant SN, Adams JC, Nadol JB Jr . Pathophysiology of Meniere’s syndrome: are symptoms caused by endolymphatic hydrops? Otol Neurotol 2005;26:74–81.
Lin MY, Timmer FC, Oriel BS et al. Vestibular evoked myogenic potentials (VEMP) can detect asymptomatic saccular hydrops. Laryngoscope 2006;116:987–992.
Morita N, Cureoglu S, Nomiya S et al. Potential cause of positional vertigo in Ménière’s disease. Otol Neurotol 2009;30:956–960.
Kato M, Teranishi M, Katayama N et al. Association between endolymphatic hydrops as revealed by magnetic resonance imaging and caloric response. Otol Neurotol 2011;32:1480–1485.
Steel KP . Perspectives: biomedicine. The benefits of recycling. Science 1999;285:1363–1364.
Sterkers O, Ferrary E, Amiel C . Production of inner ear fluids. Physiol Rev 1988;68:1083–1128.
Sawada S, Takeda T, Kitano H et al. Auaporin-2 regulation by vasopressin in the rat inner ear. NeuroReport 2002;13:1127–1129.
Hornibrool J, George P, Gourley J . Vasopressin in definite Meniere’s disease with positive electrocochleographic findings. Acta Otolaryngol 2011;131:613–617.
Robertson GL, Mahr EA, Athar S et al. The development and clinical application of a new radioimmunoassay for arginine–vasopressin in human plasma. J Clin Invest 1973;52:2340–2352.
Nussey SS, Ang VT, Bevan DH et al. Human platelet arginine vasopressin. Clin Endocrinol 1986;24:427–433.
Bichet DG, Arthus MF, Barjon JN et al. Human platelet fraction arginine-vasopressin. Potential physiological role. J Clin Invest 1987;79:881–887.
Furuta H, Luo L, Ryan AF et al. Expression of mRNA encoding vasopressin V1a, vasopressin V2, and ANP-B receptors in the rat cochlea. Hear Res 1998;117:140–148.
Furuta H, Sato C, Kawaguchi Y et al. Expression of mRNAs encoding hormone receptors in the endolymphatic sac of the rat. Acta Otolaryngol 1999;119:53–57.
Fukushima K, Takeda T, Kakigi A et al. Effects of lithium on endolymph homeostasis and experimentally induced endolymphatic hydrops. ORL 2005;67:282–288.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Laboratory Investigation website
A new animal model yields insight into the mechanisms of water homeostasis in the inner ear and the vertiginous attacks of Ménière's disease. Animals receiving electrocauterization of the endolymphatic sac and desmopressin, a vasopressin type2 receptor (VP2R) agonist, show severe endolymphatic hydrops in the cochlea and the saccule, balance disorder, and spontaneous nystagmus. These abnormalities are similar to those in patients with Ménière's disease.
Supplementary information
Rights and permissions
About this article
Cite this article
Egami, N., Kakigi, A., Sakamoto, T. et al. Morphological and functional changes in a new animal model of Ménière’s disease. Lab Invest 93, 1001–1011 (2013). https://doi.org/10.1038/labinvest.2013.91
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/labinvest.2013.91
Keywords
This article is cited by
-
Three-dimensional mouse cochlea imaging based on the modified Sca/eS using confocal microscopy
Anatomical Science International (2023)
-
Live imaging and functional changes of the inner ear in an animal model of Meniere’s disease
Scientific Reports (2020)